CXCL12-(1-17)



CXCL12-(1-17)

K1KK1P2PP2V3VV3S4SS4L5LL5S6SS6Y7YY7R8RR8C9CC9P10PP10C11CC11R12RR12F13FF13F14FF14E15EE15S16SS16H17HH17

SMILES None
InChIKey UQMATGKUTLWKOZ-DMVRXRCYSA-N
Sequence KPVSLSYRCPCRFFESH

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)


No bioactivity data available.

CXCL12-(1-17)

K1KK1P2PP2V3VV3S4SS4L5LL5S6SS6Y7YY7R8RR8C9CC9P10PP10C11CC11R12RR12F13FF13F14FF14E15EE15S16SS16H17HH17

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.